Ontology highlight
ABSTRACT: Aims
Although substantial progress has been made in understanding of ontogeny of drug metabolism, there is still a gap of knowledge in developmental pharmacogenetics in neonates. We hypothesized that both age and pharmacogenetics might explain the developmental pattern of CYP2C19. We conducted a population pharmacokinetic-pharmacogenetic study to quantify the developmental pharmacogenetics of CYP2C19 in neonates and young infants using omeprazole as a probe drug.Methods
Pharmacokinetic samples were collected from 51 Caucasian neonates and young infants, who were receiving omeprazole treatment. Population pharmacokinetic-pharmacogenetic analysis of omeprazole and its metabolites was performed using NONMEM.Results
Data fitted a one-compartment parent and metabolite mo
SUBMITTER: Zhao W
PROVIDER: S-EPMC5903239 | biostudies-literature | 2018 May
REPOSITORIES: biostudies-literature